Forte Biosciences Investor Relations Material
Latest events
Study Update
Forte Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Forte Biosciences Inc
Access all reports
Forte Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing therapies for autoimmune diseases and inflammatory skin conditions. The company is engaged in the research and development of new treatments targeting unmet medical needs. Forte Biosciences operates within the healthcare and biotechnology sectors. The company is headquartered in Dallas, Texas, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
FBRX
Country
🇺🇸 United States